132 related articles for article (PubMed ID: 15686532)
21. Beta-endorphin. Receptor binding and peripheral opioid activities of [Gln8]-, [Trp27]-, and [Tyr31]-analogs.
Ho CL; Ko JL; Li CH
Int J Pept Protein Res; 1988 Jul; 32(1):74-8. PubMed ID: 2851563
[TBL] [Abstract][Full Text] [Related]
22. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
[TBL] [Abstract][Full Text] [Related]
23. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
Mosberg HI; Heyl DL; Haaseth RC; Omnaas JR; Medzihradsky F; Smith CB
Mol Pharmacol; 1990 Dec; 38(6):924-8. PubMed ID: 2174509
[TBL] [Abstract][Full Text] [Related]
24. Comparison of mu-, delta- and kappa-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptides.
Schiller PW; Nguyen TM; DiMaio J; Lemieux C
Life Sci; 1983; 33 Suppl 1():319-22. PubMed ID: 6319885
[TBL] [Abstract][Full Text] [Related]
25. Minimum-structure enkephalin analogues incorporating L-tyrosine, D(or L)-phenylalanine, and a diamine spacer.
Jacobson AR; Gintzler AR; Sayre LM
J Med Chem; 1989 Aug; 32(8):1708-17. PubMed ID: 2754695
[TBL] [Abstract][Full Text] [Related]
26. Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids.
Galligan JJ; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Jun; 229(3):641-8. PubMed ID: 6327967
[TBL] [Abstract][Full Text] [Related]
27. Lysine substitution increases mu-selectivity of potent di- and tri-peptide enkephalin analogs.
Vavrek RJ; Cui RL; York EJ; Stewart JM; Paterson S; Kosterlitz HW
Life Sci; 1983; 33 Suppl 1():451-4. PubMed ID: 6319902
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity profiles of cyclic and linear enkephalin pseudopeptide analogs.
Edwards JV; Spatola AF; Lemieux C; Schiller PW
Biochem Biophys Res Commun; 1986 Apr; 136(2):730-6. PubMed ID: 3010995
[TBL] [Abstract][Full Text] [Related]
29. Dehydro-enkephalins. VI. Dehydroalanine3-enkephalin: a potent enkephalin analog for the delta opiate receptor.
Shimohigashi Y; Stammer CH
Int J Pept Protein Res; 1982 Sep; 20(3):199-206. PubMed ID: 6290409
[TBL] [Abstract][Full Text] [Related]
30. Effect of modification of enkephalin C-terminal functions on affinity selection of opioid receptors.
Kodama H; Uchida H; Yasunaga T; Kondo M; Costa T; Shimohigashi Y
J Mol Recognit; 1990; 3(5-6):197-203. PubMed ID: 1965778
[TBL] [Abstract][Full Text] [Related]
31. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
[TBL] [Abstract][Full Text] [Related]
32. Enkephalin analogues containing beta-naphthylalanine at the fourth position.
Mierke DF; Said-Nejad OE; Schiller PW; Goodman M
Biopolymers; 1990 Jan; 29(1):179-96. PubMed ID: 2158358
[TBL] [Abstract][Full Text] [Related]
33. Conformationally constrained cyclic enkephalin analogs with pronounced delta opioid receptor agonist selectivity.
Mosberg HI; Hurst R; Hruby VJ; Galligan JJ; Burks TF; Gee K; Yamamura HI
Life Sci; 1983 May; 32(22):2565-9. PubMed ID: 6304440
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of the opioid activity of a number of enkephalin and dermorphin analogs].
Chichenkov ON; Sumbatian NV; Riabtseva ON; Korshunova GA; Shorr VA
Farmakol Toksikol; 1988; 51(5):17-20. PubMed ID: 2850219
[TBL] [Abstract][Full Text] [Related]
35. Chimeric enkephalin-cystatins: opioid binding and structure-activity relationships of inhibitory domains.
Marks N; Berg MJ; Makofske RC; Swistok J; Simon EJ; Ofri D; Del Compare K; Danho W
Pept Res; 1992; 5(4):194-200. PubMed ID: 1330108
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological activity of delta Phe4-enkephalins.
Shimohigashi Y; Stammer CH; Costa T; Vonvoigtlander PF
Int J Pept Protein Res; 1983 Oct; 22(4):489-94. PubMed ID: 6317582
[TBL] [Abstract][Full Text] [Related]
37. Glycoconjugates of opioid peptides. Synthesis and biological activity of [Leu5]enkephalin related glycoconjugates with amide type of linkage.
Varga-Defterdarović L; Horvat S; Chung NN; Schiller PW
Int J Pept Protein Res; 1992 Jan; 39(1):12-7. PubMed ID: 1634326
[TBL] [Abstract][Full Text] [Related]
38. Side chain to side chain cyclization of an enkephalin analog results in loss of opioid receptor selectivity.
Schiller PW; Maziak LA; Lemieux C; Nguyen TM
Int J Pept Protein Res; 1986 Nov; 28(5):493-7. PubMed ID: 3028973
[TBL] [Abstract][Full Text] [Related]
39. Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue variation in a cyclic disulfide-containing opioid tetrapeptide.
Heyl DL; Omnaas JR; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI
Int J Pept Protein Res; 1991 Mar; 37(3):224-9. PubMed ID: 1651290
[TBL] [Abstract][Full Text] [Related]
40. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3.
Shenderovich MD; Nikiforovich GV; Golbraikh AA
Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
